Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes

• Главные авторы: Umair Ilyas (Автор), Muhammad Asif (Автор), Minglian Wang (Автор), Reem Altaf (Автор), Hajra Zafar (Автор), Mirza Muhammad Faran Ashraf Baig (Автор), Ana Cláudia Paiva-Santos (Автор), Muhammad Abbas (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes to control blood glucose levels. The existing research work was intended to make and optimize PGZ-containing NLCs (nanostructured lipid carriers). The fabricated nanostructured lipid carrier preparation was...